1. Home
  2. DSU vs AQST Comparison

DSU vs AQST Comparison

Compare DSU & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Debt Strategies Fund Inc.

DSU

Blackrock Debt Strategies Fund Inc.

N/A

Current Price

$9.12

Market Cap

594.7M

Sector

Finance

ML Signal

N/A

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

N/A

Current Price

$4.60

Market Cap

529.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSU
AQST
Founded
N/A
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
594.7M
529.4M
IPO Year
1998
2007

Fundamental Metrics

Financial Performance
Metric
DSU
AQST
Price
$9.12
$4.60
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.00
AVG Volume (30 Days)
237.3K
2.4M
Earning Date
01-01-0001
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,430,000.00
Revenue This Year
N/A
$10.08
Revenue Next Year
N/A
$49.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.77
52 Week Low
$9.07
$2.94
52 Week High
$10.61
$7.55

Technical Indicators

Market Signals
Indicator
DSU
AQST
Relative Strength Index (RSI) 27.26 45.27
Support Level N/A $4.03
Resistance Level $9.94 $4.69
Average True Range (ATR) 0.06 0.23
MACD -0.03 -0.09
Stochastic Oscillator 9.52 2.86

Price Performance

Historical Comparison
DSU
AQST

About DSU Blackrock Debt Strategies Fund Inc.

Blackrock Debt Strategies Fund Inc is a closed-end management investment company. Its primary investment objective is to seek to provide current income by investing in a diversified portfolio of U.S. companies debt instruments, including senior and subordinated corporate loans, both secured and unsecured, which are rated in the lower rating categories of the established rating services or unrated debt instruments, which are in the judgment of the investment adviser of equivalent quality. The Fund may invest directly in debt instruments or synthetically through the use of derivatives. The Fund's secondary investment objective is to seek to provide capital appreciation.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: